Factor XI gene mutations in factor XI deficient patients of the Czech Republic

American Journal of Hematology

Volumn 83, Issue 12, 2008, Pages 916-919

  Castaman, Giancarlo ^a   Giacomelli, Sofia H ^a   Habart, David ^b   Asselta, Rosanna ^c   Duga, Stefano ^c   Rodeghiero, Francesco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

^b Haematology and Blood Transfusion   (Czech Republic)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11; GLUTAMIC ACID; LEUCINE; PHENYLALANINE;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CASE REPORT; CZECH REPUBLIC; DISEASE SEVERITY; FEMALE; FOUNDER EFFECT; GENE MUTATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; JEW; MALE; POINT MUTATION; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ADULT; CZECH REPUBLIC; FACTOR XI DEFICIENCY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MALE; MIDDLE AGED; PEDIGREE; POINT MUTATION;

EID: 56749134139     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21286     Document Type: Article

References (26)

1. McMullen BA, Fujikawa K, Davie EW. Location of the disulfide bonds in human coagulation factor XI: The presence of tandem apple domains. Biochemistry 1991;30:2056-2060.
2. Thompson RE, Mandle R, Jr, Kaplan AP. Association of factor XI and high molecular weight kininogen in human plasma. J Clin Invest 1977;60:1376-1380.
3. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: Initiation, maintenance, and regulation. Biochemistry 1991;30:10363-10370.
4. O'Connell NM. Factor XI deficiency-from molecular genetics to clinical management. Blood Coagul Fibrinolysis 2003;14:59-64.
5. Seligsohn U. Factor XI deficiency. Textbook of Haemophilia. Oxford: Blackwell Publishing; 2005. pp 321-327.
6. Kravtsov DV, Wu W, Meijers JC, et al. Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. Blood 2004;104:128-134.
7. Kravtsov DV, Monahan PE, Gailani D. A classification system for cross-reactive material-negative factor XI deficiency. Blood 2005;105:4671-4673.
8. Shpilberg O, Peretz H, Zivelin A, et al. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood 1995;85:429-432.
9. Peretz H, Mulai A, Usher S, et al. The two common mutations causing factor XI deficiency in Jews stem from distinct founders: One of ancient Middle Eastern origin and another of more recent European origin. Blood 1997;90:2654-2659.
10. Zadra G, Asselta R, Tenchini ML, et al. Simultaneous genotyping of coagulation factor XI type II and type III mutations by multiplex real-time PCR reveals their prevalence in healthy and FXI-deficient Italians. Haematologica 2008;93:715-721.
11. Quelin F, Trossaert M, Sigaud M, et al. Molecular basis of severe factor XI deficiency in seven families from the west of France. Seven novel mutations, including an ancient Q88X mutation. J Thromb Haemost 2004;2:71-76.
12. Zivelin A, Bauduer F, Ducout L, et al. Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood 2002;99:2448-2454.
13. Bolton-Maggs PH, Peretz H, Butler R, et al. A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency. J Thromb Haemost 2004;2:918-924.
14. Bolton-Maggs PH, Young Wan-Yin B, McCraw AH, et al. Inheritance and bleeding in factor XI deficiency. Br J Haematol 1988;69:521-528.
15. Salomon O, Steinberg DM, Seligshon U. Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy. Haemophilia 2006;12:490-493.
16. De Raucourt E, de Mazancourt P, Quelin F. Four novel gene mutations in three factor XI-deficient patients. Blood Coagul Fibrinolysis 2008;19:240-242.
17. Duncan EM, Casey GJ, Fenech MP, et al. Partial and severe factor XI deficiency in South Australia and the usefulness of factor XI mutation analysis for diagnosis. Pathology 2008;40:401-406.
18. Dai L, Mitchell M, Carson P, et al. Severe factor XI deficiency caused by compound heterozygosity. Br J Haematol 2004;125:817-818.
19. Kunicki TJ, Federici AB, Salomon DR, et al. An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees. Blood 2004;104:2359-2367.
20. Baglia FA, Badellino KO, Ho DH, et al. A binding site for the kringle II domain of prothrombin in the apple 1 domain of factor XI. J Biol Chem 2000;275:31954-31962.
21. Meijers JC, Mulyhill ER, Davie EW, et al. Apple four in human blood coagulation factor XI mediates dimer formation. Biochemistry 1992;31:4680-4684.
22. Meijers JC, Davie EW, Chung DW. Expression of human blood coagulation factor XI: Characterization of the defect in factor XI type III deficiency. Blood 1992;79:1435-1440.
23. Mitchell M, Cutler J, Thompson S, et al. Heterozygous factor XI deficiency associated with three novel mutations. Br J Haematol 1999;107:763-765.
24. Hill M, McLeod F, Franks H, et al. Genetic analysis in FXI deficiency: Six novel mutations and the use of a polymerase chain reaction-based test to define a whole gene deletion. Br J Haematol 2005;129:825-829.
25. O'Connell NM, Saunders RE, Lee CA, et al. Structural interpretation of 42 mutations causing factor XI deficiency using homology modeling. J Thromb Haemost 2005;3:127-138.
26. Castaman G, Giacomelli SH, Dragani S, et al. Severe factor XI deficiency in Abruzzo Region of Italy is associated to different FXI gene mutations. Haematologica 2008;93:957-958.